GLP-1 Receptor Agonists: A Breakthrough in Cardiovascular Health
Discover the breakthrough role of GLP-1 receptor agonists in cardiovascular health, FDA-approved for patients managing diabetes and obesity.
OIG Report Highlights Medicare Overpayments for Continuous Glucose Monitors
The HHS OIG report reveals Medicare Part B overpayments for continuous glucose monitors and supplies, recommending rate reductions to align with supplier costs and enhance program efficiency.
AI-Driven Predictive Analytics Enhance Diabetes Care and Reduce Medicare Costs
Explore how AI-powered predictive analytics improve diabetes management and reduce Medicare costs through personalized patient adherence interventions.
Medicare Drug Coverage and Costs for Jardiance in Heart Failure and Diabetes Care
Explore how Medicare Part D and C plans cover Jardiance for heart failure and type 2 diabetes, including costs, formularies, and pricing reforms under the Inflation Reduction Act.